Xcell Therapeutics Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-10,927	-9,543	-9,281	-8,342	-9,038
Depreciation & Amortization	1,704	1,653	1,598	1,513	1,019
Loss (Gain) From Sale of Assets	-98.66	130.13	-21	0.53	12
Asset Writedown & Restructuring Costs	-	-	154.12	-	-
Loss (Gain) From Sale of Investments	-19.02	-2.72	0.87	-	-
Loss (Gain) on Equity Investments	0.81	-	-	-	-
Stock-Based Compensation	127.83	228.31	283.67	540.12	354.46
Provision & Write-off of Bad Debts	89.27	259.89	50	-	-
Other Operating Activities	379.71	383.97	587.39	230.17	3,453
Change in Accounts Receivable	72.06	-31.37	-301.81	-104.98	-133.14
Change in Inventory	-537.37	60.58	-178.38	-186.23	179.52
Change in Accounts Payable	91.59	46.38	43.66	-137.29	-239.85
Change in Other Net Operating Assets	-385.34	-180.91	280.29	-808.69	-211.69
Operating Cash Flow	-9,502	-6,996	-6,784	-7,296	-4,605
Capital Expenditures	-866.72	-382.69	-224.82	-1,179	-1,347
Sale of Property, Plant & Equipment	165.05	-	55	-	0.45
Sale (Purchase) of Intangibles	-316.58	-437.34	-8.83	-145.48	-49.14
Investment in Securities	-3,771	-1,780	-3.96	-131.88	-3.88
Other Investing Activities	-17.64	1,328	4.06	-10	-259.51
Investing Cash Flow	-4,807	-1,272	-178.55	-1,466	-1,659
Long-Term Debt Issued	700	1,950	350	-	3,000
Long-Term Debt Repaid	-1,395	-3,035	-587.44	-455.54	-759.28
Net Debt Issued (Repaid)	-695.48	-1,085	-237.44	-455.54	2,241
Issuance of Common Stock	9,220	15,875	3,000	16.66	8,092
Other Financing Activities	119.13	-0	-	-	-
Financing Cash Flow	8,644	14,790	2,763	-438.88	14,232
Foreign Exchange Rate Adjustments	-5.69	1,239	2.2	4.66	2.15
Net Cash Flow	-5,671	7,761	-4,197	-9,196	7,971
Free Cash Flow	-10,369	-7,379	-7,008	-8,475	-5,952
Free Cash Flow Margin	-532.01%	-381.48%	-623.58%	-830.82%	-302.69%
Free Cash Flow Per Share	-890.07	-737.67	-792.48	-968.02	-718.67
Cash Interest Paid	280.96	343.69	284.27	209.73	104.88
Cash Income Tax Paid	-11.26	23.06	-8.31	11.26	3.73
Levered Free Cash Flow	-6,769	-5,076	-3,926	-5,606	-6,886
Unlevered Free Cash Flow	-6,766	-5,074	-3,924	-5,604	-6,774
Change in Working Capital	-759.05	-105.33	-156.23	-1,237	-405.17

Source: S&P Global Market Intelligence. Standard template. Financial Sources.